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Viral Degradation of the MHC Class I
Peptide Loading Complex
ubiquitinates the cytoplasmic tails of newly synthesized
MHC class I heavy chains, leading to their rapid, protea-
some-dependent degradation (Boname and Stevenson,
Jessica M. Boname,1 Brigitte D. de Lima,1
Paul J. Lehner,2 and Philip G. Stevenson1,*
1Division of Virology and
2 Division of Immunology 2001). Thus in L929 cells, H2-Db lacking its cytoplasmic
tail is neither bound nor downregulated by MK3,Department of Pathology
University of Cambridge whereas H2-Db lacking cytoplasmic lysine residues is
bound but largely resists downregulation.Tennis Court Road
Cambridge CB2 1QP MK3-deficient MHV-68 shows a marked, CD8-depen-
dent reduction in B cell latency amplification (StevensonUnited Kingdom
et al., 2002), consistent with the detection of MK3 tran-
scripts in infected lymphoid tissue (Rochford et al., 2001;
Stevenson et al., 2002; Marques et al., 2003). MK3 mustSummary
therefore overcome two particular obstacles to CD8
T cell evasion. First, MHV-68 activates B cells (Steven-The murine -herpesvirus-68 MK3 protein inhibits
CD8 T cell recognition by ubiquitinating the cyto- son and Doherty, 1999), and activated B cells can pres-
ent peptides to CD8 T cells via nonclassical MHC classplasmic tails of classical MHC class I heavy chains.
Here we show that MK3 also provides the first example I glycoproteins such as Qa-1 and Qa-2 (Oudshoorn-
Snoek and Demant, 1989; Vidovic et al., 1989; Shawarof a protein that degrades tapasin and TAP. The degra-
dation was MK3 RING finger dependent and primarily et al., 1994; Das et al., 2000). Second, MHV-68-infected
lymphoid tissue contains large numbers of interferon-affected TAP. MK3 associated with TAP1 in the ab-
sence of tapasin or TAP2, suggesting that TAP1 was (IFN-)-producing T cells (Stevenson et al., 1999; Chris-
tensen and Doherty, 1999). IFN- upregulates cellulara primary binding partner in the peptide loading com-
plex. TAP2 also played a major role in MK3 stability and antigen presentation (Pamer and Cresswell, 1998) and
can overcome CD8 T cell evasion by either the Herpesfunction. By degrading TAP, therefore, MK3 limited
its own expression. However, TAP degradation also simplex virus ICP-47 TAP inhibitor (Tigges et al., 1996;
Posavad et al., 1998) or the multiple evasion proteins ofbroadened the MK3 inhibitory repertoire and achieved
a remarkable resistance to MHC class I upregulation the murine (Hengel et al., 1994) or human cytomegalovi-
ruses (Hengel et al., 1995). How might MK3 augmentby interferon-, suggesting that it represents a spe-
cific adaptation to immune evasion in lymphoid tissue. simple classical MHC class I degradation—also an ac-
tion of several cytomegalovirus evasion proteins—to en-
sure CD8 T cell evasion in lymphoid tissue? BecauseIntroduction
MK3 associates with the peptide loading complex as
well as with MHC class I (Yu et al., 2002), one possibilityCD8 T cell evasion is a common theme of herpesvirus
biology. However, the mechanisms employed are re- is an additional inhibition of MHC class I assembly. The
cytoplasmic dispositions of the N- and C-terminal do-markably diverse. The intimate relationship between im-
munity and immune evasion means that understanding mains of MK3 (Boname and Stevenson, 2001) make any
direct attack on proteins confined to the ER lumen un-how viral evasion works can potentially tell us a great
deal about normal immune function. The best described likely: an ER loop of only 11 amino acid residues sepa-
rates the 2 transmembrane domains of MK3, and theCD8 T cell evasion mechanism of -herpesviruses is
MHC class I ubiquitination, mediated by homologous small size and tethered ends of this loop would confine
it to the phospholipid head group layer of the inner ERzinc finger proteins of the murine -herpesvirus-68
(MHV-68) (Stevenson et al., 2000; Boname and Steven- membrane. However, tapasin, TAP, and immunoprotea-
somes are all potential targets for MK3 in MHC classson, 2001; Yu et al., 2002; Lybarger et al., 2003) and
the Kaposi’s sarcoma-associated herpesvirus (KSHV) I assembly.
(Ishido et al., 2000; Coscoy and Ganem, 2000; Coscoy MK3 has been reported to inhibit the association of
et al., 2001; Hewitt et al., 2002; Means et al., 2002; Lo- 2-microglobulin (2M) with MHC class I heavy chains
renzo et al., 2002). The herpesviral proteins also have (Yu et al., 2002). However, this claim was based on what
cellular (Jenner and Boshoff, 2002; Goto et al., 2003) appears to have been an artifact of 2M detection by
and poxviral homologs (Guerin et al., 2002; Mansouri et metabolic labeling (Lybarger et al., 2003). Thus there
al., 2003), each with a variant RING zinc binding finger has been no indication to date that MK3 does more than
(Aravind et al., 2003; Scheel and Hofmann, 2003) and two catalyze MHC class I degradation. Here we show that
or more transmembrane domains. Thus a fundamental MK3 triggers the degradation of the MHC class I peptide
pathway of cellular protein catabolism appears to have loading complex as a second mechanism of CD8 T cell
been pirated for immune evasion. evasion. This degradation extended MK3-mediated im-
The MHV-68 K3 protein (MK3) resides in the endoplas- mune evasion to a nonclassical MHC class I glycoprotein
mic reticulum (ER) membrane, where it binds to and that is inaccessible to ubiquitination, and also appeared
to afford considerable resistance to MHC class I upregu-
lation by IFN-.*Correspondence: pgs27@mole.bio.cam.ac.uk
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Figure 1. Downregulation of Nonclassical MHC Class I Glycoproteins by MK3
(A–F) Flow cytometric analysis of cell surface MHC class I on (A and B) H2b RMA cells, (C) H2d A20 cells, (D) H2k L929 cells, (E) H2d BALB/
c-3T3 cells, and (F) H2b MEF-1 cells, each expressing either MK3 (solid lines) or a nonfunctional mutant with two cysteine residues of the
RING domain changed to glycines (MK3-MUT, dotted lines). The latter were indistinguishable from untransduced cells or cells transduced
with empty retrovirus. Equivalent data were obtained in five independent experiments. (A) Downregulation of Qa-1 and Qa-2 with preservation
of Thy-1. (B) Qa-2 downregulation on RMA cells by MK3 in which a myc epitope tag replaced the central 6 residues of the 11 amino acid ER
loop. (C) Downregulation of Qa-2 on A20-MK3 cells and comparison with H2-Kd. The BALB/c-AnN mice from which A20 cells were derived
lack endogenous Qa-2, and so were transduced with either H2-Q7 cDNA, encoding native Qa-2 (A20-Q7), or a mutant form in which the 2 C
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Results domain-specific mAb 28.14.8 immunoprecipitated com-
parable amounts of signal from RMA and RMA-MK3
cells after a 15 min 35S-cys/met label, reflecting the inter-Downregulation of Qa-1 and Qa-2 by MK3
Since MK3 protects virus-infected germinal center B val between MHC class I heavy chain synthesis and
degradation; after a 90 min chase, very little signal wascells against CD8 T cell recognition, and activated B
cells present antigens to CD8 T cells on both classical recovered from RMA-MK3 cells. In contrast, Qa-2 recov-
ery from RMA-MK3 cells with mAb 1-1-2 was alreadyand nonclassical MHC class I molecules, we tested
whether MK3 could downregulate the nonclassical gly- reduced after a 15 min label, but was then relatively
preserved over the ensuing 90 min (Figure 1H). The effectcoproteins Qa-1 and Qa-2 (Figure 1) in addition to H2-D,
H2-K, and H2-L. Not surprisingly, MK3 downregulated of MK3 on Qa-2 was thus qualitatively different to that
on H2-Db, with no evidence of rapid degradation. MAbQa-1 (Figure 1A), which has a fairly well conserved
form (KRRRHI) of the cytoplasmic MK3 binding motif 1-1-2 recognizes a Qa-2 12 domain epitope (Sharrow
et al., 1989), suggesting that it is sensitive to defects in(KRRRNT) and distal lysine residues for ubiquitination.
However, MK3 also downregulated Qa-2 (Figure 1A), peptide loading. This was supported by the inability of
mAb 1-1-2 to recover Qa-2 from TAP2-deficient RMA/Swhich has a glycosyl phosphatidyl inositol (GPI) mem-
brane anchor and so lacks any cytoplasmic domain for cells (Figure 1I). Thus an impaired assembly of the Qa-2
heavy chain with peptide was a possible explanationMK3 binding or ubiquitin transfer. A control GPI-linked
protein, Thy-1, was unaffected (Figure 1A). for the decreased Qa-2 recovery from RMA-MK3 cells.
Because MK3 still down-regulates ubiquitination-
resistant H2-Db to a minor degree (Boname and Steven- Impaired MHC Class I Peptide Loading
in the Presence of MK3son, 2001), it was important to check if MK3 downregu-
lated Qa-2 by binding it even without ubiquitination. The If Qa-2 assembly was impaired, classical MHC class I
complexes made in the presence of MK3 should alsoshort, ER-lumenal MK3 loop could have bound to the
extracellular domain of Qa-2, or MK3 could have bound have lacked optimal peptides prior to their degradation.
Our previous immunoprecipitation of pulse-labeledto 2 cytoplasmic arginine residues that are present in
the H2-Q7 Qa-2 gene product before GPI anchor attach- H2-Db from RMA-MK3 cells with the peptide-dependent
B22.249 mAb (Boname and Stevenson, 2001) would ap-ment. To identify any contribution of such interactions
to Qa-2 downregulation, we replaced the bulk of the pear to argue against this. However, when RMA-MK3
cell lysates were incubated at 37C prior to immunopre-MK3 ER loop with a myc epitope tag (Figure 1B) and
mutated both cytoplasmic arginine residues to glutamic cipitation, it became clear that the B22.249-reactive
H2-Db conformation was unstable (Figures 2A and 2B).acid (Q7-MUT) (Figure 1C). Neither change compro-
mised Qa-2 downregulation, which thus appeared to be We also found reduced H2-Kb stability in RMA-MK3 cell
lysates using the peptide-dependent Y3 mAb (data notindependent of a direct interaction with MK3.
The downregulation of Qa-2 apparently contradicted shown). The loss of B22.249-reactive H2-Db at 37C was
not due to heavy chain degradation, since H2-Db recov-the failure of MK3 in L929 cells to either bind or downreg-
ulate H2-Db lacking its cytoplasmic tail (Boname and ery from RMA-MK3 cell lysates with the peptide-inde-
pendent 28.14.8 mAb was preserved (Figure 2A). ThusStevenson, 2001). However, consistent with our previ-
ous results, MK3 did not downregulate Qa-2 in L929 prior to their degradation, classical MHC class I com-
plexes in cells expressing MK3 exhibited impaired as-cells (Figure 1D). MK3 therefore harnessed an additional
mechanism beyond MHC class I heavy chain ubiquitina- sembly.
The lack of labeled 2M coprecipitating with MHCtion to attack Qa-2 in RMA and A20 cells. Qa-2 was
also downregulated by MK3 in BALB/c-3T3 and MEF-1 class I heavy chains in the presence of MK3—even from
lysates kept on ice that preserved the 2M-dependentfibroblasts (Figures 1E and 1F). MHV-68-infected MEF-1
cells also showed a small but consistent MK3-depen- B22.249 epitope (Figure 2A, RMA-MK3, t 0)— has also
been noted in L929 cells (Yu et al., 2002), which showeddent downregulation of Qa-2 (Figure 1G).
We analyzed the downregulation of endogenous Qa-2 no evidence of MK3-mediated Qa-2 downregulation
(Figure 1D). The most likely explanation is that unlabeledfurther by metabolic labeling and immunoprecipitation
of Qa-2 from RMA-MK3 cells (Figure 1H). The H2-Db 3 2M accumulated in the ER of RMA-MK3 cells due to
terminal cytoplasmic arginine residues present before GPI anchor attachment were changed to glutamic acid residues (Q7-MUT). (D) No Qa-2
downregulation on L929-MK3 cells. The C3H mice from which L929 cells were derived lack endogenous Qa-2 and so were transduced with
native H2-Q7 cDNA, as for A20-Q7 cells in (C). (E) Downregulation of the same Qa-2 expressed in H2d BALB/c-AnN-3T3 cells. (F) Downregulation
of endogenous Qa-2 in MEF-1 cells. For Qa-2 staining, these cells were pretreated with IFN- (20 U/ml, 48 hr) to induce higher expression levels.
(G) MEF-1 cells were left uninfected (solid lines) or infected (5 PFUcell, 18 hr) with wild-type (dashed lines) or MK3-deficient MHV-68 (dotted
lines, made by inserting an FRT site into the MK3 RING finger [Stevenson et al., 2002]). All cells were then stained for H2-Db, H2-Kb, and Qa-2,
or with secondary antibody only (nil). Qa-2 levels on cells infected with MK3 viruses were 79 / 6% of levels on uninfected cells (mean /
SD of three experiments). Qa-2 levels on cells infected with MK3 viruses were 106 / 3% of those on uninfected cells.
(H) RMA and RMA-MK3 cells were treated with IFN- for 48 hr, and then pulse labeled for 15 min with 35S-cys/met and chased for 2 hr with
an excess of unlabeled cys/met. Cell lysates were divided for immunoprecipitation of H2-Db with mAb 28.14.8 or Qa-2 with mAb 1-1-2. Qa-2
samples were treated () or not () with endoglycosidase H (endoH). Precipitates were then resolved by SDS-PAGE and exposed to X-ray
film. The two endoH-sensitive bands immunoprecipitated by mAb 1-1-2 correspond to the immature forms of GPI-linked and secreted Qa-2
(Stroynowski et al., 1987).
(I) Cells were pulse labeled for 2 hr and Qa-2 was immunoprecipitated as above. MAb 1-1-2 failed to recover labeled Qa-2 from TAP2-deficient
RMA/S or RMA/S-MK3 cells.
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Figure 2. Impaired Classical MHC Class I As-
sembly with Peptide in the Presence of MK3
(A) RMA and RMA-MK3 cells were labeled for
10 min with 35S-cys/met. Cell lysates were
then incubated at 37C for varying times be-
fore transfer to 4C. At the end of the time
course, H2-Db was immunoprecipitated from
all samples with either a peptide-dependent
(B22.249) or a peptide-independent (28.14.8)
mAb, and analyzed by SDS-PAGE. Data from
one of two equivalent experiments are
shown.
(B) Graphs show the H2-Db signal intensity of
the immunoprecipitates above, as a fraction
of the t  0 value.
(C) RMA, RMA/S (TAP2-deficient), RMA-
MK3-MUT, and RMA-MK3 cells were labeled
for 15 min with 35S-cys/met and then lysed in
1% Triton X-100 buffer with or without addi-
tional cognate peptide (1 M SIINFEKL for
H2-Kb, 1 M ASNENMETM for H2-Db). Prop-
erly folded H2-Kb and H2-Db complexes were
then immunoprecipitated with mAbs Y3 and
B22.249, respectively. The bar graph shows
the fold increase in heavy chain recovery with
additional peptide.
(D) RMA, RMA/S, and RMA-MK3 cells were
incubated overnight at 31C and then shifted
to 37C for 3 hr in the presence or absence
of cognate peptide (50 M SIINFEKL for H2-
Kb, 50 M ASNENMETM for H2-Db). Cells
were then stained for surface MHC class I.
The graph shows the fold increase in geomet-
ric mean fluorescence intensity with cognate
peptide in one of two equivalent experiments.
ongoing heavy chain degradation and competed with increased the recovery of pulse-labeled H2-Kb with mAb
Y3 and the H2-Db binding peptide ASNENMETM in-labeled 2M for nascent H2-Db heavy chains (Townsend
et al., 1990; Lybarger et al., 2003). The lack of coprecipi- creased the recovery of pulse-labeled H2-Db with mAb
B22.249. The recovery of folded, pulse-labeled MHCtating 2M was therefore apparent rather than real, a
consequence of visualizing H2-Db by metabolic labeling class I was increased in all lines, but much more so in
RMA-MK3 cells and TAP2-deficient RMA/S cells. Exog-rather than a manifestation of impaired MHC class I
complex assembly. We found no evidence for MK3 enous peptide also increased the cell surface levels of
H2-Db and H2-Kb on RMA-MK3 cells (Figure 2D).causing a loss of calnexin (see below), the chaperone
that promotes 2M binding to MHC class I heavy chains H2-Db lacking its cytoplasmic tail is not bound by MK3
and in L929 cells is not downregulated (Boname and(Pamer and Cresswell, 1998).
Adding exogenous peptide to RMA-MK3 lysates prior Stevenson, 2001). As with Qa-2, however, the tail-less
H2-Db mutant was downregulated in A20 cells (Figureto immunoprecipitation supported the idea of impaired
MHC class I complex assembly due to a lack of peptide 3A) and in BALB/c-3T3 cells (data not shown). Culturing
A20-MK3 cells with exogenous H2-Db binding peptide(Figure 2C). Thus, the H2-Kb binding peptide SIINFEKL
MHV-68 Immune Evasion
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Figure 3. Downregulation of Tailless H2-Db without Degradation in A20-MK3 Cells
(A) A20 cells (H2d) were transduced with either MK3 or the inactive mutant MK3-MUT, and with either full-length H2-Db (H2-Db-L) or H2-Db in
which the entire cytoplasmic domain was replaced by a myc epitope tag (H2-Db-VS, Boname and Stevenson, 2001). These cell lines were
incubated overnight at 31C, shifted to 37C for 4 hr in the presence or absence of an H2-Db binding peptide (50 M ASNENMETM), and then
stained with anti-H2-Db (dotted lines), anti-H2-Dd (dashed lines), or an isotype control mAb (solid lines).
(B) The same cell lines were pulse-labeled for 15 min with 35S-cysteine/methonine and then chased for 45 or 90 min. All samples were
immunoprecipitated with mAb 28.14.8, which recognizes H2-Db and H2-Ld.
(Figure 3A) rescued the expression of full-length H2-Db Impaired Peptide Transport in the Presence of MK3
We next assayed peptide transport into the ER of cellsonly poorly, consistent with heavy chain degradation.
The small population of cells showing rescue were prob- expressing MK3. There was a modest but highly repro-
ducible transport deficit in RMA-MK3 cells (Figure 4A)ably those in the polyclonal population with relatively low
MK3 expression. In contrast, tail-less H2-Db expression and a more substantial deficit in A20-MK3 cells (Figure
4B). Thus impaired peptide transport into the ER ap-was substantially rescued by exogenous peptide. Here,
therefore, a lack of peptide appeared to be the major peared a likely cause of the impaired MHC class I assem-
bly. The transport deficit depended on the MK3 RINGcause of downregulation.
Pulse-chase metabolic labeling and immunoprecipi- domain, since RING domain mutants actually caused an
increase in peptide transport. Surprisingly, a significanttation (Figure 3B) confirmed that tail-less H2-Db, unlike
full-length H2-Db, was not degraded in A20-MK3 cells. defect in peptide transport remained even after IFN-
treatment (Figure 4C).Instead, it remained intact in a predominantly low molec-
ular weight form, implying retention in the ER/cis-Golgi
due to improper folding. The same molecule in A20- MK3-Mediated Degradation of the Peptide
Loading ComplexMK3-MUT cells substantially matured over the chase
period. In A20-MK3 cells, therefore, there was evidence Peptide transport is reduced in cells lacking either ta-
pasin or TAP (Lehner et al. 1998). We therefore quanti-for both H2-Db degradation and impaired H2-Db as-
sembly. tated TAP1, TAP2, and tapasin in MK3-expressing cells
Immunity
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Figure 4. Decreased Peptide Transport in the Presence of MK3
(A) RMA, RMA-MK3-MUT, RMA-MK3-DEL, RMA/S, and RMA-MK3 cells were permeabilized with streptolysin-O and tested for their capacity
to transport 125I-labeled RRYQNSTEL peptide into the ER. Transported peptide was recovered on the basis of N-linked glycosylation by
precipitation with Con A-sepharose. Precipitated counts are shown as a function of transport time at 37C.
(B) In similar assays, we compared A20, A20-MK3-MUT, A20-MK3, and RMA/S cells. Consistent data were obtained in three separate experi-
ments.
(C) A20 cells with or without MK3 were treated with IFN (20 U/ml, 48 hr) prior to the peptide transport assay. This failed to reverse the MK3-
dependent deficit.
by immunoblotting (Figure 5A). TAP1, TAP2, and tapasin LMP7 levels were normal (Figure 5A), as were those of
the LMP2, MECL-1, and 20S proteasomal subunits (datalevels were all reduced in A20-MK3 cells, with TAP1
and TAP2 the most affected. Calnexin, calreticulin, and not shown). Decreased tapasin and, more obviously,
Figure 5. Reduced Levels of Peptide Load-
ing Complex Components in Cells Express-
ing MK3
(A) Lysates from A20-MK3, A20-MK3-MUT,
RMA-MK3, AND RMA-MK3-MUT cells were
immunoblotted as indicated. Reduced levels
of tapasin, TAP1, and TAP2 in the presence
of MK3 and normal levels of calnexin, calreti-
culin, and LMP7 were observed in three inde-
pendent experiments.
(B) RMA, RMA-MK3, and RMA-MK3-MUT
cells were treated with IFN- for 48 hr, labeled
for 15 min with 35S-cys/met (P), and chased
with an excess of unlabeled cys/met for 7
(C7) or 22 hr (C22). Cell lysates were divided
for immunoprecipitations of TAP1, TAP2, and
tapasin. Rabbit anti--actin pAb was in-
cluded in each immunoprecipitation to pro-
vide a loading control. The graphs show the
signal intensity at each time point for RMA
(closed squares), RMA-MK3 (open circles),
and RMA-MK3-MUT cells (closed circles),
corrected for -actin signal and expressed
relative to the pulse (P) value. The data shown
are representative of three independent ex-
periments.
(C) Lysates from A20, A20-MK3, and A20-
MK3-MUT cells were immunoblotted for
TAP1, TAP2, and tapasin as shown. There
was a small but consistent increase in the
levels of tapasin and TAP2 in A20-MK3-MUT
cells compared to A20 cells in three sepa-
rate experiments.
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Figure 6. The Effect of IFN- on MHC Class
I Downregulation by MK3 in Different Cell
Lines
(A) Cells expressing either MK3 or MK3-MUT
were left untreated (solid line histograms) or
exposed for 48 hr to 100 U/ml IFN- (dotted
line histograms). Cells were then stained for
cell surface MHC class I expression as indi-
cated, or with an isotype control antibody
(filled histograms). Similar results were ob-
tained in four independent experiments.
(B) Summarizes the data in Figures 1A–1F and
6A. MEF-1-MK3 cells showed some upregu-
lation of H2-Db with IFN- treatment (2.2-fold),
but still less than MEF-1-MK3-MUT cells (9.9-
fold). Qa-2 downregulation on MEF-1 cell de-
rivatives could only be examined with IFN-
treatment. NT, not tested.
(C) A20 and L929 cells, either untransduced
or expressing MK3 or MK3-MUT, were cul-
tured with or without IFN- (100 U/ml, 48 hr).
Cell lysates were then separated by SDS-
PAGE and immunoblotted with anti-flag M2
mAb to quantitate MK3 expression.
(D) BALB/c 3T3-MK3 and BALB/c 3T3-MK3-
MUT cells were cultured with or without IFN-
(100 U/ml, 48 hr) and then labeled for 15 min
with 35S-cysteinemethionine (P) and chased
for 2 hr with an excess of unlabeled cys-
teinemethionine (C). H2-Dd, H2-Kd, and -actin
(as a loading control) were immunoprecipi-
tated from cell lysates and analyzed by SDS-
PAGE. The identities of the individual bands
were confirmed by comparison with single
antibody immunoprecipitations (not shown).
(E) Cells stably transduced with MK3 or MK3-
MUT were treated or not with IFN- (20 U/ml,
72 hr) and then processed for immunoblotting
of cell lysates for TAP1, TAP2, and tapasin.
decreased TAP2 levels were also evident in RMA-MK3 prolonged the half-lives of tapasin, TAP1, and TAP2
(Figure 5B), in keeping with the observed increase incells, although TAP1 was relatively preserved. Pulse-
chase metabolic labeling and immunoprecipitation of peptide transport (Figure 4). There were also increased
steady-state levels of tapasin and TAP2 in A20-MK3-tapasin, TAP1, and TAP2 confirmed an accelerated loss
of these proteins in the presence of MK3 (Figure 5B). MUT cells compared to A20 controls (Figure 5C). The
requirement for the MK3 RING domain in TAP and ta-An increased rate of degradation rather than a reduced
rate of synthesis thus appeared to be the cause of their pasin degradation, as in H2-Db degradation (Boname
and, Stevenson 2001), implied that ubiquitination waslower steady state levels.
An MK3 RING domain mutant (MK3-MUT) actually involved, as would be expected for the disposal of inte-
Immunity
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Figure 7. MK3 Stability and Function in the Absence of TAP2
(A) RMA cells and their TAP2-deficient derivative RMA/S were transduced with flag-tagged MK3 or MK3-MUT and immunoblotted for tapasin,
TAP1, TAP2, and the flag epitope.
(B) The same cell lines were pulse labeled (P) for 15 min with 35S-cys/met and chased (C) for 2 hr with an excess of unlabeled cys/met. H2-
Db was immunoprecipitated from cell lysates with mAb 28.14.8 and MK3 with anti-flag mAb M2. Precipitates were resolved by SDS-PAGE.
MK3 recovery after the chase was 66% of the pulse value in RMA cells and 15% in RMA/S cells. The recovery for MK3-MUT was 66% and
6%, respectively.
(C) RMA/S cells expressing MK3 or MK3-MUT were transduced or not with TAP2 and stained unfixed with anti-H2-Db (mAb 28.14.8, dotted
lines), anti-H2-Kb (mAb Y3, dashed lines), or secondary antibody only (solid lines). MK3 downregulated cell surface MHC class I only when
intact TAP2 was present.
(D) The same cell lines as in (C), plus RMA/S-TAP2 cells, were pulse-labeled for 15 min with 35S-cys/met and chased for 90 min with
excess unlabeled cys/met. H2-Db and flag-tagged MK3 or MK3-MUT were then immunoprecipitated with mAbs 28.14.8 and M2, respectively.
Precipitates were resolved by SDS-PAGE and exposed to X-ray film.
(E) MK3 and H2-Db were immunoprecipitated from lysates of RMA and RMA/S cells with or without MK3-MUT, using anti-flag mAb or mAb
28.14.8. Precipitates were separated by SDS-PAGE and immunoblotted for TAP1 and TAP2. The identity of the faint, smaller band detected
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gral ER membrane proteins. However, the relatively slow ration due to impaired peptide loading. Similar results
were obtained with H2-Db and H2-Kb in RMA-MK3 cellsturnover of TAP and tapasin coupled to the cytotoxicity
of proteasome inhibitors meant that we were unable to (data not shown). IFN- treatment substantially upregu-
lated steady state levels of peptide loading complexdemonstrate this directly (data not shown).
components in BALB/c-3T3-MK3-MUT and A20-MK3-
MUT cells and L929 cells containing either MK3-MUT
The Effect of IFN- on MHC Class I or MK3, while the steady state levels in IFN--treated
Downregulation by MK3 BALB/c-3T3-MK3 and A20-MK3 cells remained rela-
A key aspect of MHV-68 immune evasion in lymphoid tively low (Figure 6E). This provided a likely explanation
tissue is the likely exposure of cells expressing MK3 to for the failure of IFN- to reverse the peptide transport
IFN-. Although IFN- is generally a potent antagonist deficit in A20-MK3 cells. MEF-1-MK3 cells showed some
of viral immune evasion, IFN- treatment (100 U/ml, 48 upregulation of TAP components by IFN-, in keeping
hr) had surprisingly little effect on the cell surface MHC with their partial susceptibility to of MHC class I upregu-
class I expression of RMA-MK3 cells (Figure 6A). TNF- lation. We conclude, therefore, that MK3 prevented the
(5 ng/ml, 48 hr) was similarly ineffective, as was a combi- upregulation of cell surface MHC class I expression by
nation of TNF- and IFN-: for example, IFN- plus virtue of a dual attack on the antigen presentation path-
TNF- treatment increased H2-Kb expression 3.5-fold way: degradation of the peptide loading complex limited
on RMA-MK3-MUT cells but only 2.2-fold on RMA-MK3 the rate of MHC class I assembly, such that MK3-medi-
cells, and increased H2-Db expression 1.8-fold on RMA- ated heavy chain degradation was not overwhelmed.
MK3-MUT cells but decreased it 1.2-fold on RMA-MK3 The lack of peptide loading complex degradation in
cells. A20-MK3 and BALB/c-3T3-MK3 cells showed a L929-MK3 cells (Figure 6E) was consistent with their
similar resistance of MHC class I downregulation to re- lack of Qa-2 downregulation or resistance to IFN-.
versal by IFN- (Figure 6A) or TNF- (not shown). In
contrast, IFN- strongly upregulated MHC class I ex-
pression on L929 and BW5147 cells expressing MK3 The Role of TAP2 in MK3 Function
A lack of either tapasin or TAP1 has been shown to(Figure 6A). MEF-1 cells showed an intermediate pheno-
type. A comparison of different cell lines (Figure 6B) impair MK3 stability (Lybarger et al., 2003). However,
whether a lack of either molecule affected MK3 directlyestablished that the capacity of MK3 to downregulate
Qa-2 correlated with its capacity to resist MHC class I or only by a secondary destabilization of the peptide
loading complex was not determined. The fact that TAPupregulation by IFN-.
There was no evidence that transcription from the appeared to be a key target for MK3-mediated degrada-
tion (Figure 5) raised the question of whether MK3 degra-retroviral promoter used to drive MK3 expression was
altered by IFN- treatment, as this caused	5% variation dation targets were also required for MK3 stability, that
is, whether TAP degradation limited MK3 expression.in the geometric mean fluorescence intensity of cells
expressing retroviral promoter-driven green fluorescent TAP2 appeared to be a major target for MK3-mediated
degradation. We therefore analyzed MK3 function inprotein. Also, MK3 did not interfere with cytokine signal-
ing, since IFN- increased cell surface I-Ad expression TAP2-deficient RMA/S cells (Powis et al., 1991; Attaya
et al., 1992) (Figures 7A–7C).equally on A20-MK3 cells and untransduced A20 con-
trols (2.3-fold and 2.0-fold, respectively). Steady state TAP1 and tapasin levels were not obviously affected
by an absence of TAP2 (Figure 7A). However, both MK3MK3 levels increased with IFN- treatment, probably
because of increased numbers of peptide loading com- and MK3-MUT levels were low in RMA/S cells compared
to RMA controls. Pulse-chase metabolic labeling andplexes being available for MK3 binding, but no more in
A20-MK3 cells (IFN--resistant) than in L929-MK3 cells immunoprecipitation (Figure 7B) confirmed that both
MK3 and MK3-MUT turned over more rapidly in the(IFN--sensitive) (Figure 6C).
Pulse-chase metabolic labeling (Figure 6D) showed absence of TAP2. It was also clear that TAP2 was re-
quired for MK3 to degrade H2-Db (Figure 7B): H2-Dbthat the increased rate of H2-Dd synthesis stimulated
by IFN- in BALB/c-3T3-MK3 cells was matched by an failed to mature in RMA/S-MK3 cells, consistent with an
absence of peptide transport, but showed no evidenceincreased rate of degradation. Very little signal was re-
covered by the end of the chase. H2-Kd degradation of rapid degradation. MK3 further caused no loss of
tapasin in RMA/S cells (Figure 7A). Restoring TAP2 ex-proceeded somewhat less rapidly. However, the resid-
ual H2-Kd in IFN--treated BALB/c-3T3-MK3 cells at the pression to RMA/S cells rescued MK3 function (Figures
7C and 7D) and MK3 stability (Figure 7D). MK3 wasend of the chase remained in a predominantly lower
molecular weight form, consistent with a failure of matu- therefore specifically compromised by an absence of
with anti-TAP2 in anti-flag precipitates of RMA/S-MK3-MUT cells was unclear.
(F) Tapasin/ MC2 fibroblasts, or control tapasin/ MC6 fibroblasts were transduced or not with MK3-MUT and subjected to immunoprecipita-
tion with anti-flag mAb. Precipitates were separated by SDS-PAGE and immunoblotted for flag-tagged MK3-MUT and for peptide loading
complex components as shown.
(G) Flag-tagged MK3 derivatives, either with a disrupted RING domain (MK3-MUT) or with a 39 amino acid C-terminal truncation (MK3-CT),
were immunoprecipitated from RMA cells. MK3-MUT binds to MHC class I, whereas MK3-CT does not (Boname and Stevenson, 2001).
Precipitates were separated by SDS-PAGE and immunoblotted for peptide loading complex components and the flag epitope tag as shown.
(H) MK3-CT was immunoprecipitated from RMA-MK3-CT and RMA/S-MK3-CT cells with anti-flag M2 mAb. Immunoprecipitates and whole
cell lysates were immunoblotted for TAP1, TAP2 and the flag epitope.
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TAP2 rather than by another mutation that might have to MK3 stability, which would explain why MK3 is poorly
expressed in TAP1-deficient cells (Lybarger et al., 2003).arisen during the empirical derivation of the RMA/S cell
TAP2 stabilized MK3 independent of TAP1 stability (Fig-line (Ljunggren and Karre, 1986).
ure 7). This argued for an additional direct interactionWe then asked whether MK3 still associated with
between TAP2 and MK3. However, we could not ruleTAP1 in RMA/S cells, using MK3-MUT to avoid the com-
out TAP2 stabilizing MK3-MUT by altering TAP1 confor-plication of MHC class I and TAP2 degradation (Figure
mation or by recruiting MHC class I to TAP (Figure 7E).7E). Immunoprecipitating MK3-MUT still coprecipitated
Whatever the mechanism, the crucial role of TAP2 inTAP1, albeit in reduced amounts. MK3 could therefore
MK3 stability meant that by degrading TAP2, MK3 im-bind TAP1 independently of TAP2. Interestingly, the as-
paired its own expression and function. This inherentsociation of H2-Db with TAP in RMA cells, particularly
adjustment of MK3-mediated immune evasion to thewith TAP1, was greatly enhanced by MK3-MUT (Figure
level of cellular antigen presentation may allow MHV-687E), implying that in the absence of ubiquitination, MK3
to use the same evasion protein in a wide range ofprovided a stabilizing bridge between H2-Db and TAP1.
settings, without causing excessive MHC class I down-TAP1 was not detectably associated with H2-Db in the
regulation and predisposing to NK cell attack.absence of TAP2, regardless of the presence of MK3-
A second aspect of MK3 adjusting to the level ofMUT. Thus the nonfunctionality of the residual MK3 in
cellular antigen presentation was observed in IFN--RMA/S cells (Figure 7B) was probably due to MHC class
treated cells (Figure 6). Here, enhanced MK3 functionI not properly associating with the peptide loading com-
offset a higher rate of in MHC class I synthesis andplex (Powis et al., 1997).
assembly to keep cellular antigen presentation low. ToMK3 also remained associated with TAP1 in the ab-
some extent this might be expected from a greater MK3sence of tapasin (Figure 7F). It was not possible to deter-
stabilization by higher levels of peptide loading complexmine whether this association was diminished, since
components (Lybarger et al., 2003). However, MK3 func-TAP levels are considerably reduced in tapasin-deficient
tion was reversed most effectively in L929-MK3 cells,cells (Garbi et al., 2003), but the data supported the idea
which because of a lack of TAP degradation showed thethat MK3 bound TAP directly rather than via tapasin.
greatest increase in TAP levels with IFN-. This pointedThe MK3-CT C-terminal truncation mutant, which does
toward TAP degradation being the key to IFN- resis-not bind to MHC class I (Boname and Stevenson, 2001),
tance. H2-Db expression in RMA-MK3 cells actually de-associated much less well than MK3-MUT with the pep-
creased with IFN- treatment, implying a qualitative in-tide loading complex (Figure 7G). Thus MHC class I may
crease in MK3 function in IFN--treated cells.have a role in this interaction. TAP2 influenced MK3
One possibility for the IFN- resistance is a changeby more than just MHC class I recruitment, since the
in TAP composition. In resting cells, only a third of TAPassociation of MK3-CT with TAP1 was further decreased
heterodimers actively transport peptides (Reits et al.,in RMA/S cells (Figure 7H). TAP2 therefore played a
2000). IFN-presumably increases this fraction, increas-central role in the interaction of MK3 with the peptide
ing peptide delivery and ensuring maximal TAP occupa-loading complex, so by degrading TAP2, MK3 limited
tion by tapasin (Ortmann et al., 1997). It may also pro-its own expression. Nevertheless, this second action of
mote TAP complex multimerization (Marguet et al.,MK3 ensured a broader and more robust downregula-
1999). One or more such changes could allow MK3 totion of cellular antigen presentation.
target TAP more efficiently.
Another possibility is that IFN--treated cells have a
Discussion greater capacity for TAP degradation. The low rate of
TAP degradation by MK3 in comparison to MHC class
In order to evade CD8T cells in virus-infected lymphoid I degradation was not surprising, as the normal turnover
tissue, MK3 must cope both with nonclassical MHC of TAP is also low: a viral protein that exploits cellular
class I glycoproteins that are inaccessible to cyto- degradation pathways will inevitably be limited by the
plasmic tail ubiquitination and with a milieu rich in proin- availability and activity of degradation pathway compo-
flammatory cytokines. TAP degradation thus appeared nents. Newly synthesized MHC class I molecules must
to be a highly relevant second mechanism of immune bind peptides to be useful. Those that bind peptide
evasion: it broadened the MK3 inhibitory repertoire to poorly must be actively degraded to prevent them accu-
include Qa-2 and conferred a unique resistance to MHC mulating on TAP. This would imply that an efficient cellu-
class I upregulation by IFN-. TAP degradation also pro- lar pathway of MHC class I ER degradation is constantly
vides a rationale for the association between MK3 and maintained, ripe for exploitation by MK3. In contrast,
TAP, which would otherwise represent a severe con- the cell has little reason to turn over TAP rapidly. TAP
straint on MK3 function. is therefore likely to be more resistant to degradation.
The close interactions between peptide loading com- For example, it may be efficiently deubiquitinated by
plex components can make it difficult to determine the cellular enzymes. One time TAP levels must be reduced,
importance of individual proteins in processes such as however, is during the return to normal antigen presenta-
interaction with MK3. For example, TAP is unstable in tion after IFN- stimulation. This would predict that IFN-
the absence of tapasin (Garbi et al., 2003), so the instabil- both increases TAP synthesis and, in a more delayed
ity of MK3 in tapasin-deficient cells (Lybarger et al., fashion, clears the way for TAP degradation. Higher lev-
2003; Figure 7F) may simply reflect a lack of TAP. The els of cellular cofactors for TAP degradation could there-
coprecipitation of MK3 and TAP1 even when TAP2 or fore explain why MK3 functioned more efficiently in
tapasin was absent (Figure 7) argued that MK3 bound IFN--treated cells.
Although we were unable to demonstrate TAP ubiqui-TAP1 directly. TAP1 must therefore contribute directly
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(Boname and Stevenson, 2001) and lysed on ice for 30 min in 50tination directly, the requirement of TAP degradation for
mM TrisCl (pH 7.4), 150 mM NaCl, 1 mM PMSF, with Completethe MK3 RING finger strongly suggested that as with
protease inhibitors (Roche) and either 1% Triton X-100 or 1% digito-MHC class I degradation, ubiquitination plays a central
nin (Sigma Chemical Co., Poole, UK). For immune precipitation of
role. One limitation of substrate ubiquitination as an TAP1, TAP2, or tapasin, cells were lysed with 5 mM DTT and 1%
immune evasion mechanism is that it relies on accessi- SDS, heated (70C, 10 min), cooled (5 min, 25C), and treated with
12.5 mM iodoacetamide (5 min, 25C). Lysates were diluted in 10ble lysine residues that might not be crucial for protein
volumes of 1% Triton X-100 lysis buffer, cleared by centrifugationfunction. Host susceptibility can therefore vary relatively
(13,000 
 g, 15 min) and incubation (18 hr, 4C) with formalin-fixedfree of functional constraints. Sequence comparison of
S. aureus (Sigma) plus protein A-Sepharose (Sigma) or streptavidin-the susceptible H2d and H2b alleles of TAP1 and TAP2
sepharose (Amersham-Pharmacia Biotech, Amersham, UK).
with the resistant H2k allele (Marusina et al., 1997) did H2-Kb was immunoprecipitated with the conformation-dependent
not reveal an obvious feature such as an altered lysine mAb Y3 (Townsend et al., 1990). H2-Db was immunoprecipitated with
mAb 28-14-8 (BD Biosciences, Oxford, UK), which is independent ofresidue that might have decreased susceptibility to deg-
peptide loading, or mAb B22.249 (kindly provided by Dr. T. Elliot,radation by MK3—in fact the H2d and H2k alleles are
University of Southampton, UK), which is sensitive to peptide load-generally more similar to each other than either is to the
ing (Townsend et al., 1990), in each case followed by proteinH2b allele—but there could equally be allelic variation in
A-Sepharose. In some experiments, the H2-Db binding peptide
posttranslational modifications of TAP or in degradation ASNENMETM or the H2-Kb binding peptide SIINFEKL were added
pathway components such as a cellular E2 ubiquitin (1 M) at the time of cell lysis.
Qa-2 was immunoprecipitated with biotinylated mAb 1-1-2 (BDconjugating enzyme. MHV-68 perhaps compensates for
Biosciences) followed by streptavidin-sepharose. Flag-tagged MK3the haplotype limitations on MK3 function by also using
was precipitated with anti-flag mAb M2-agarose (Sigma). Tapasina chemokine binding protein to evade CD8 T cells
and TAP1 were precipitated with goat anti-murine tapasin pAb and(Bridgeman et al., 2001; Rice et al., 2002). Every immune
goat anti-murine TAP1 pAb (Santa Cruz Biotechnology, Santa Cruz,
evasion mechanism has its weaknesses and strengths. CA) plus protein G agarose (Sigma). TAP2 was precipitated with
Only as our understanding of the whole virus increases sheep anti-rat TAP2 pAb (kindly provided by Dr. Simon Powis, Uni-
versity of Dundee, UK) plus protein G agarose. Beads were washeddo these mechanisms begin to fit into a coherent frame-
3
 in 1% Triton X-100 buffer or 0.1% digitonin buffer. Endoglycosi-work of parasite survival.
dase H (New England Biolabs, Beverly, MA) was used according to
the manufacturer’s instructions. Samples were dissociated at 70CExperimental Procedures
in Laemmli’s buffer prior to SDS-PAGE.
Plasmids
Retroviral expression plasmids containing MK3, an inactive RING Immunoblotting
domain mutant (MK3-MUT), an inactive N-terminal truncation mu- Cells were lysed as above, and either the postnuclear lysate or
tant (MK3-DEL), or an inactive C-terminal truncation mutant (MK3- immunoprecipitates were heated in Laemmli’s buffer, followed by
CT), each with a 5 flag epitope tag, have been described previously, SDS-PAGE and transfer to PVDF membranes. Blots were probed
as have retroviral expression plasmids containing full-length, myc with goat pAb to TAP1 or tapasin, rabbit pAb to TAP2 (a kind gift
epitope-tagged H2-Db or H2-Db with a myc epitope tag replacing from Dr. J. Monaco, University of Cincinnati), calnexin (Stressgen,
its entire cyoplasmic tail (Boname and Stevenson, 2001). MK3-CT Victoria, Canada), calreticulin (Stressgen), or LMP7 (Affiniti Research
does not show detectable H2-Db binding; MK3-MUT and MK3-DEL Products, Exeter, UK), or a biotinylated murine anti-flag mAb
bind H2-Db but do not catalyze its ubiquitination. We used overlap (Sigma), followed by horseradish peroxidase-conjugated rabbit anti-
PCR (Hi-fidelity, Roche Diagnostics, Lewes, UK) to replace 6 amino goat IgG pAb (Sigma), donkey anti-rabbit IgG pAb (Amersham) or
acids between the MK3 transmembrane domains (NGFLSP) with a streptavidin (Amersham) and developed with SuperSignal West Dura
myc epitope tag (EQKLISEEDL). This MK3 mutant was cloned into extended duration enhanced chemiluminescent substrate (Pierce
pMSCV-IRES-PURO. TAP2 was cloned by RT-PCR from IFN-- Biotechnology Inc., Rockford, IL).
treated L929 cells (RNAzol B, Tel-Test, Friendswood, TX). MfeI and
SalI recognition sites were included in the 5 and 3 primers, respec-
Peptide Translocation Assaytively. The PCR product was cloned into 5 EcoRI site and 3 XhoI
Peptide translocation assays were performed as previously de-sites of pMSCV-NEO for retroviral transduction of RMA/S cells. To
scribed (Lehner et al., 1998). Cells were permeabilized with streptoly-mutate the C-terminal 2 arginines of H2-Q7, a primer was designed
sin-O, pelleted, resuspended in 50 mM HEPES, 78 mM KCl, 4 mMto encode glutamic acids in their place, upstream of a termination
MgCl2, 8.4 mM CaCl2,10 mM EGTA, 1 mM dithiothreitol, 0.1% bovinecodon and XhoI site. This form of Qa-2 (Q7-MUT) was also cloned
serum albumin, 2 mM ATP, and incubated (1-10 min, 37C) withinto pMSCV-IRES-ZEO. All inserts and mutations were checked by
125I-labeled RRYQNSTEL peptide. Aliquots were harvested by addingDNA sequencing.
ice-cold Triton X-100 lysis buffer. Nuclei and cell debris were then
pelleted (13,000
 g, 15 min), and N-glycosylated peptide recoveredCell Lines
with Con A-Sepharose beads (Sigma). The beads were washed 3
RMA (H2b), MEF-1 (H2b) and L929 cells (H2k), with and without MK3
in lysis buffer and bound 125I-labeled peptide was quantitated byexpression, have been described previously (Boname and Steven-
-counting.son, 2001). A20 cells (H2d) (American Type Culture Collection TIB-
208) were obtained from Professor F.K. Stevenson (Tenovus Re-
search Laboratories, Southampton, UK). MC2 (tapasin/) and MC6 Flow Cytometry
(tapasin/) fibrosarcoma cells, derived from tapasin-deficient and Cells were washed in PBSBSA (0.1%) azide (0.01%), incubated (15
immunocompetent control mice (Garbi et al., 2000), were kindly min, 4C) with 10% rabbit serum, and stained (1 hr, 4C) using bio-
provided by Dr. N. Garbi and Dr. G. Ha¨mmerling (Deutsches Krebs- tinylated anti-Qa-2 (1-1-2), biotinylated anti-Qa-1 (6A8.6F10.1A6),
forschungszentrum, Heidelberg). Replication-defective retroviruses biotinylated anti-H2-Kd (SF1-1.1), biotinylated anti-H2-Dd (34-2-12),
were generated as previously described (Stevenson et al., 2000). biotinylated anti-H2-Db (KH-95) anti-Thy-1 (G7) (BD Pharmingen),
Transduced cells were selected with 600 g/ml Zeocin (Invitrogen FITC-conjugated anti-H2-Dk (Serotec, Oxford, UK), anti-H2-Db
Ltd, Paisley, UK), 20 g/ml puromycin, or 1 mg/ml G418. (28.14.8) and anti-H2-Kb (Y3). A20 cells were blocked with 10%
mouse serum and unlabeled anti-CD16/32 (BD Pharmingen) for 30
min prior to staining. The binding of unlabeled antibodies was de-Metabolic Labeling and Immune Precipitation
Cells were metabolic labeled with 35S-cysteine/methionine (cys/met) tected with FITC-conjugated streptavidin (Serotec) or FITC-conju-
gated rabbit anti-mouse IgG (Dako Ltd., Ely, UK). After 2 washes in(PerkinElmer Life Sciences, Cambridge, UK) as previously described
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ice-cold PBS, cells were analyzed on a FACS Calibur using Cellquest Hengel, H., Esslinger, C., Pool, J., Goulmy, E., and Koszinowski,
U.H. (1995). Cytokines restore MHC class I complex formation and(BD Pharmingen) and FCSPress v1.3 (www.fcspress.com).
control antigen presentation in human cytomegalovirus-infected
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